Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
174.2500 -4.86 (-2.71%)
NSE Sep 22, 2025 15:31 PM
Volume: 1.1M
 

174.25
-2.71%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Marksans Pharma Ltd.'s price crossed below 30Day SMA today
More from Marksans Pharma Ltd.
Recommended